Datopotamab deruxtecan
Term · Oncology and biomedicine · MLC-T-ONC-002290
A drug used to treat adults with breast cancer that cannot be removed by surgery or has spread to other parts of the body, has been treated with other therapies, and is hormone receptor positive (HR+) and HER2-negative. It is also being studied in the treatment of other types of cancer. Datopotamab deruxtecan contains a monoclonal antibody called datopotamab that binds to a protein called TROP2, which is found on some cancer cells. It also contains an anticancer drug called deruxtecan, which may help kill cancer cells. Datopotamab deruxtecan is a type of antibody-drug conjugate. Also called Datroway.
| Identifier | MLC-T-ONC-002290 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Datroway |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-002290",
"term": "Datopotamab deruxtecan",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat adults with breast cancer that cannot be removed by surgery or has spread to other parts of the body, has been treated with other therapies, and is hormone receptor positive (HR+) and HER2-negative. It is also being studied in the treatment of other types of cancer. Datopotamab deruxtecan contains a monoclonal antibody called datopotamab that binds to a protein called TROP2, which is found on some cancer cells. It also contains an anticancer drug called deruxtecan, which may help kill cancer cells. Datopotamab deruxtecan is a type of antibody-drug conjugate. Also called Datroway.",
"synonyms": [
"Datroway"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/datopotamab-deruxtecan/"
}
Record 5,711 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.